Author

Vincent Fregona

Centre National de la Recherche ScientifiqueORCID 0000-0003-4857-1737Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Organism:human· 2 Assay:scRNA-seq· 2 Research Focus:clustering· 1 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1

Frequent Co-Authors

Adriane HalikiD· 1 shared André BarucheliD· 1 shared Andreas TrumppiD· 1 shared Anne Quillet‐MaryiD· 1 shared Bastien GerbyiD· 1 shared Caroline Röthemeier· 1 shared Carsten Mueller-Tidow· 1 shared Christine DidieriD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Adriane HalikORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintAug 26, 2026

Multiscale biological interactions define clinical trajectories in acute myeloid leukemia

Jan Bařinka, Sarah Gräßle, Magdalena Pajonk…·Simon Haas

This study links multiscale biological interactions to clinical outcomes in AML by analyzing single-cell data and developing an analytical framework.

DOI 10.64898/2026.08.25.746926

𝕏 PostBluesky

Cancer BiologybioRxivPreprintDec 18, 2025

Targeting glucocorticoid-induced CD20 activation in preclinical models of B-ALL

Jérémy Bigot, Mathieu Bouttier, Vincent Fregona…·Bastien Gerby

This study identifies CD20 as an actionable target in B-ALL MRD using PDX models and single-cell RNA sequencing, showing anti-CD20 antibodies can eradicate drug-resistant cells.

DOI 10.64898/2025.12.16.694550

𝕏 PostBluesky